|
Volumn 325, Issue 7373, 2002, Pages 1131-
|
Controversial stroke trial is under review following BMJ report.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLASMINOGEN ACTIVATOR;
TISSUE PLASMINOGEN ACTIVATOR;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONFLICT OF INTEREST;
DRUG INDUSTRY;
HUMAN;
MEDICAL SOCIETY;
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE;
NOTE;
PRACTICE GUIDELINE;
STANDARD;
UNITED STATES;
AMERICAN HEART ASSOCIATION;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIALS;
CONFLICT OF INTEREST;
DRUG INDUSTRY;
HUMANS;
PLASMINOGEN ACTIVATORS;
PRACTICE GUIDELINES;
TISSUE PLASMINOGEN ACTIVATOR;
UNITED STATES;
|
EID: 18744371297
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.325.7373.1131 Document Type: Note |
Times cited : (6)
|
References (0)
|